469 related articles for article (PubMed ID: 36614005)
1. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
Skelding KA; Barry DL; Theron DZ; Lincz LF
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia.
Ladikou EE; Sivaloganathan H; Pepper A; Chevassut T
Curr Oncol Rep; 2020 Feb; 22(3):27. PubMed ID: 32048054
[TBL] [Abstract][Full Text] [Related]
3. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cells: major players in acute myeloid leukaemia.
Fodil S; Arnaud M; Vaganay C; Puissant A; Lengline E; Mooney N; Itzykson R; Zafrani L
Blood Rev; 2022 Jul; 54():100932. PubMed ID: 35148910
[TBL] [Abstract][Full Text] [Related]
5. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
6. Targeting N-cadherin (CDH2) and the malignant bone marrow microenvironment in acute leukaemia.
Parker J; Hockney S; Blaschuk OW; Pal D
Expert Rev Mol Med; 2023 May; 25():e16. PubMed ID: 37132370
[TBL] [Abstract][Full Text] [Related]
7. Targeting integrins in drug-resistant acute myeloid leukaemia.
Ogana HA; Hurwitz S; Wei N; Lee E; Morris K; Parikh K; Kim YM
Br J Pharmacol; 2024 Jan; 181(2):295-316. PubMed ID: 37258706
[TBL] [Abstract][Full Text] [Related]
8. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
[TBL] [Abstract][Full Text] [Related]
9. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
10. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
[TBL] [Abstract][Full Text] [Related]
11. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
[TBL] [Abstract][Full Text] [Related]
12. What is the role of the bone marrow microenvironment in AML?
Mulherkar N; Scadden DT
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101328. PubMed ID: 34865700
[TBL] [Abstract][Full Text] [Related]
13. Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance.
Miari KE; Williams MTS
Br J Pharmacol; 2024 Jan; 181(2):216-237. PubMed ID: 36609915
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of the Leukaemia Microenvironment.
Kuek V; Hughes AM; Kotecha RS; Cheung LC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206957
[TBL] [Abstract][Full Text] [Related]
15. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.
Ahmed HMM; Nimmagadda SC; Al-Matary YS; Fiori M; May T; Frank D; Patnana PK; Récher C; Schliemann C; Mikesch JH; Koenig T; Rosenbauer F; Hartmann W; Tuckermann J; Dührsen U; Lanying W; Dugas M; Opalka B; Lenz G; Khandanpour C
Br J Haematol; 2022 Feb; 196(4):995-1006. PubMed ID: 34792186
[TBL] [Abstract][Full Text] [Related]
19. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.
Roversi FM; Cury NM; Lopes MR; Ferro KP; Machado-Neto JA; Alvarez MC; Dos Santos GP; Giardini Rosa R; Longhini AL; Duarte ADSS; Pericole FV; Favaro P; Yunes JA; Saad STO
J Cell Mol Med; 2019 Feb; 23(2):1562-1571. PubMed ID: 30484958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
